Clinical Trial Results:
RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND EFFICACY STUDY
OF THE EMOLLIENT V0034CR IN ADDITION TO A MODERATELY POTENT CORTICOSTEROID IN THE ACUTE PHASE OF TREATMENT OF ATOPIC DERMATITIS IN INFANTS.
Summary
|
|
EudraCT number |
2005-002803-18 |
Trial protocol |
FR FI EE LV DE |
Global completion date |
07 Nov 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
21 Nov 2018
|
First version publication date |
21 Nov 2018
|
Other versions |
v2 |
Summary report(s) |
synopsis v0034CR307 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.